When analyzing pooled data from patients with different cancer types, our results showed higher levels of infiltrating of CD8 cells, lower levels of infiltrating of M2 macrophages, higher TMB, and higher expression of immune checkpoint molecules in the SETD2 deleterious mutation group. The gene discussed is SETD2; the disease is cancer.